Memantine potentiates agonist-induced Ca + responses in HEK 293 cells

Cellular Physiology and Biochemistry

Volumn 22, Issue 1-4, 2008, Pages 205-214

  Blanchard, Alexandre P ^a   Guillemette, Gaetan ^a   Boulay, Guylain ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Alzheimer; Calcium signaling; Inositol 1,4,5 trisphosphate receptor; Memantine; PP2A; SERCA

Indexed keywords

CALCIUM ION; CARBACHOL; INOSITOL 1,4,5 TRISPHOSPHATE; MEMANTINE; OKADAIC ACID; SAPONIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; EXCITOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

EID: 51149101036     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149798     Document Type: Article

References (42)

1. LaFerla FM: Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002;3:862-872.
2. Bell KF, Claudio Cuello A: Altered synaptic function in Alzheimer's disease. Eur J Pharmacol 2006;545:11-21.
3. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993;361:315-325.
4. Putney JW, Jr.: A model for receptor-regulated calcium entry. Cell Calcium 1986;7:1-12.
5. Putney JW, Jr., Broad LM, Braun FJ, Lievremont JP, Bird GS: Mechanisms of capacitative calcium entry. J Cell Sci 2001;114:2223-2229.
6. Hofmann T, Schaefer M, Schultz G, Gudermann T: Transient receptor potential channels as molecular substrates of receptor-mediated cation entry. J Mol Med 2000;78:14-25.
7. Golde TE: Disease modifying therapy for AD? J Neurochem 2006;99:689-707.
8. Erdo SL, Schafer M: Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 1991;198:215-217.
9. Parsons CG, Danysz W, Quack G: Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 1999;38:735-767.
10. Bormann J: Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 1989;166:591-592.
11. Reiser G, Binmoller FJ, Koch R: Memantine (1-amino-3,5- dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line. Brain Res 1988;443:338-344.
12. Rammes G, Rupprecht R, Ferrari U, Zieglgansberger W, Parsons CG: The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett 2001;306:81-84.
13. Masuo K, Enomoto K, Maeno T: Effects of memantine on the frog neuromuscular junction. Eur J Pharmacol 1986;130:187-195.
14. Tsai MC, Chen ML, Lo SC, Tsai GC: Effects of memantine on the twitch tension of mouse diaphragm. Eur J Pharmacol 1989;160:133-140.
15. Buisson B, Bertrand D: Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 1998;53:555-563.
16. Maskell PD, Speder P, Newberry NR, Bermudez I: Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br J Pharmacol 2003;140:1313-1319.
17. Aracava Y, Pereira EF, Maelicke A, Albuquerque EX: Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther 2005;312:1195-1205.
18. Grossmann A, Grossmann W, Jurna I: The effect of dimethylaminoadamantane on neuronal membranes. Eur J Pharmacol 1976;35:379-388.
19. Grossmann W, Jurna I: [The effect of memantine (dimethylaminoadamantane) on membranes of sensory nerve fibres (author's transl)]. Arzneimittelforschung 1977;27:1483-1487.
20. Klee MR: [Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica]. Arzneimittelforschung 1982;32:1259-1267.
21. Netzer R, Bigalke H: Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures. Eur J Pharmacol 1990;186:149-155.
22. McLean MJ: In vitro electrophysiological evidence predicting anticonvulsant efficacy of memantine and flunarizine. Pol J Pharmacol Pharm 1987;39:513-525.
23. Boulay G, Zhu X, Peyton M, Jiang M, Hurst R, Stefani E, Birnbaumer L: Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein. J Biol Chem 1997;272:29672- 29680.
24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
25. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
26. Martin V, Bredoux R, Corvazier E, Van Gorp R, Kovacs T, Gelebart P, Enouf J: Three novel sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 3 isoforms. Expression, regulation, and function of the membranes of the SERCA3 family. J Biol Chem 2002;277:24442-24452.
27. Zhu X, Jiang M, Birnbaumer L: Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry. J Biol Chem 1998;273:133-142.
28. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, LaFerla FM: Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 2000;149:793-798.
29. Mistry R, Wilke R, Challiss RA: Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex. Br J Pharmacol 1995;114:797-804.
30. Chohan MO, Khatoon S, Iqbal IG, Iqbal K: Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. FEBS Lett 2006;580:3973-3979.
31. Li L, Sengupta A, Haque N, Grundke-Iqbal I, Iqbal K: Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Lett 2004;566:261-269.
32. Liu M, Parker LL, Wadzinski BE, Shieh BH: Reversible phosphorylation of the signal transduction complex in Drosophila photoreceptors. J Biol Chem 2000;275:12194-12199.
33. Popescu DC, Ham AJ, Shieh BH: Scaffolding protein INAD regulates deactivation of vision by promoting phosphorylation of transient receptor potential by eye protein kinase C in Drosophila. J Neurosci 2006;26:8570-8577.
34. Drever BD, Anderson WG, Johnson H, O'Callaghan M, Seo S, Choi DY, Riedel G, Platt B: Memantine acts as a cholinergic stimulant in the mouse hippocampus. J Alzheimers Dis 2007;12:319-333.
35. McLarnon JG, Choi HB, Lue LF, Walker DG, Kim SU: Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. J Neurosci Res 2005;81:426-435.
36. Giacomello M, Barbiero L, Zatti G, Squitti R, Binetti G, Pozzan T, Fasolato C, Ghidoni R, Pizzo P: Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis 2005;18:638-648.
37. Zatti G, Burgo A, Giacomello M, Barbiero L, Ghidoni R, Sinigaglia G, Florean C, Bagnoli S, Binetti G, Sorbi S, Pizzo P, Fasolato C: Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 2006;39:539-550.
38. Zatti G, Ghidoni R, Barbiero L, Binetti G, Pozzan T, Fasolato C, Pizzo P: The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores. Neurobiol Dis 2004;15:269-278.
39. Lessard CB, Lussier MP, Cayouette S, Bourque G, Boulay G: The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells. Cell Signal 2005;17:437-445.
40. Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, Handler M, Shen J, Xia W, Tesco G, Saunders AJ, Ding K, Frosch MP, Tanzi RE, Kim TW: Presenilin-mediated modulation of capacitative calcium entry. Neuron 2000;27:561-572.
41. O'Neill C, Cowburn RF, Bonkale WL, Ohm TG, Fastbom J, Carmody M, Kelliher M: Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease. Biochem Soc Symp 2001:177-194.
42. Musial A, Bajda M, Malawska B: Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 2007;14:2654-2679.